HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Miguel A. Castro José L. Pomar Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mestres, C.-A. Articles by the Hospital Clinic Endocarditis Study Group, Search for Related Content PubMed PubMed Citation Articles by Mestres, C.-A. Articles by the Hospital Clinic Endocarditis Study Group, Related Collections Cardiac - other

Eur J Cardiothorac Surg 2003;23:1007-1016
© 2003 Elsevier Science NL

Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1)

^a Department of Cardiovascular Surgery, Hospital Clínico, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
^b Infectious Diseases Service-Institut Clinic Infeccions Inmunologia (ICII), Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
^c Hospital de Basurto, Bilbao, Spain

Received 27 October 2002; received in revised form 10 March 2003; accepted 11 March 2003.

^* Corresponding author. Tel.: +34-93-227-5515; fax: +34-93-451-4898
e-mail: cmestres{at}clinic.ub.es

Objectives: Assessment of long-term results of immunodeficiency virus type-1 (HIV-1)-infected patients undergoing cardiac surgery. Methods: Retrospective analysis of profile and outcomes of 31 HIV-1-infected patients (35 operations, 1985–2002). Results: Twenty-seven males and four females (mean age 34.67) in three groups: acute infective endocarditis (AIE) 21 (67.74%), coronary (CAD) 5 (16.13%) and non-infective valvular disease (NIVD) 5 (16.13%). HIV factors: drug addiction (23–74.19%), homosexuality (5–16.12%), heterosexuality (3–9.67%), hemodialysis (1–3.22%). HIV stage: A (17), B (2), C (2) in AIE; A (2), B (3) in CAD and A (3), C (2) in NIVD. Mean preoperative CD4 count was 278 cells/µL (12<200 cells/µL, 38.7%). The most frequent pathogens: S. aureus (52.38%), S. viridans (23.8%), Candida (19.04%). Native valve involved in 22 cases (78.33%) and prostheses in 8 (26.67%); 8.57% were operated in 1980–1985, 14.28% in 1986–1990, 22.85% in 1991–1995 and 54.28% in 1996–2002 with 16 elective (48.17%), 17 urgent (45.71%) and two emergencies (5.71%); mean aortic clamping and cardiopulmonary bypass time 78.9 and 107.47 min. Hospital mortality was 22.58 and 28.57% in AIE. No CAD patient died. Nine patients (37.5%) died between 2 and 171 months (mean 54.5). Mortality was 50% in AIE. CD4 count increased from 185.33 to 396.55 cells/µL (P=0.43) in nine patients on antiretrovirals. Fifteen-year actuarial survival is 58.16% overall and 48.01% for AIE. Conclusions: There is an increase in HIV-1-infected patients requiring cardiac surgery, a decrease in AIE, however NIVD and CAD increasingly seen. Cardiac surgery did not blunt CD4 response induced by antiretrovirals. The late cause of death were not AIDS-related events.

Key Words: Cardiac surgery • Human immunodeficiency virus • Endocarditis • Intravenous drug abusers • Homosexuality • Antiretroviral therapy

This article has been cited by other articles:

				C. A. Mestres, M. A. Castro, E. Bernabeu, M. Josa, R. Cartana, J. L. Pomar, J. M. Miro, J. Mulet, and the Hospital Clinico Endocarditis Study Group Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 281 - 285. [Abstract] [Full Text] [PDF]

				A. Wahba and D. Nordhaug What are the long-term results of cardiac valve replacements in left sided endocarditis with a history of i.v. drug abuse? Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 608 - 610. [Abstract] [Full Text] [PDF]

				L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation, June 14, 2005; 111(23): e394 - e434. [Abstract] [Full Text] [PDF]